Delivery Order SPE2DB20D1100-SPE2DB23FD0W7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $7,125.00 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,563,205,093 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,687.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,833,076 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This delivery order has an ultimate completion date of October 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies. This award appears to be part of a larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $3,669.68 for the supply of 4,563,451,766 units of XEOMIN 100 unit vials. The delivery order is set to be completed by February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through an Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,871,380 units of XEOMIN 100 unit vials. The contract has a potential value of $4,718.16 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to provide a comprehensive range of pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,301,682 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The $6,667.40 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a $10,485.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,496,211 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,057.69 firm fixed-price delivery order is for the supply of 4,565 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,639.28 firm-fixed-price contract is for the supply of 4,565,970,488 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD0W7Delivery Order
The U.S. Defense Logistics Agency awarded a $40,082.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,562,991,153 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. This contract has a completion date of September 5, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The company has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.1k | 8/14/23 |